Serimmune is an immune intelligence company based in Santa Barbara, CA that specializes in decoding the complexity of human antibody response. Their proprietary Serum Epitope Repertoire Analysis (SERA) technology platform utilizes bacterial display peptide libraries, next-generation sequencing, machine learning, and custom bioinformatics to identify disease-specific epitopes across proteins and entire proteomes. With their universal serology assay, Serimmune empowers discovery projects and offers immune profiling services to academia, government, and industry, providing a broad view of an individual's immune responses to environmental exposures in both disease and health.
Founded on the belief that the information encoded in an individual's functional antibody repertoire is crucial for understanding human disease, Serimmune aims to build and interpret a dynamic map of human immunity. Their technology has shown linkages between antibody response to pathogens in various complex diseases, including oncology, autoimmune, infectious, and neurodegenerative conditions. Through their innovative approach, Serimmune contributes to target discovery, biomarker identification, and the development of immunotherapeutics and vaccines.
Generated from the website